BioLineRx

BLRXNasdaq Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$11.792 M

$2.71 -2.87%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

2,610,814,390

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#424Akari TherapeuticsAKTX$12.3M
#425Phio PharmaceuticalsPHIO$12.1M
#426BioLineRxBLRX$11.8M
#427Kiora PharmaceuticalsKPRX$11.7M
#428BullFrog AIBFRG$10.9M

Where these numbers come from

Share counts and financials for BioLineRx are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.